Who is sponsoring NCT03078634?

NCT03078634 is sponsored by St Vincent's Hospital Melbourne.

What drugs are being tested in NCT03078634?

Interventions in NCT03078634: Multi-disciplinary clinic model, Standard outpatient care.

What condition does NCT03078634 study?

NCT03078634 studies Irritable Bowel Syndrome, Functional Dyspepsia, Constipation - Functional, Faecal Incontinence, Functional Abdominal Pain Syndrome, Other Rome IV Functional Gastrointestinal Disorders.

Is NCT03078634 still recruiting?

NCT03078634 is currently completed. Last updated 29 November 2023.

Last reviewed 2023-11-29 · How we verify

NCT03078634: MANTRA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Multi-disciplinary Treatment of Functional Gut Disorders Study

Completed NA Last updated 29 November 2023

What this trial tests

NA trial testing Multi-disciplinary clinic model in Irritable Bowel Syndrome in 188 participants. Completed in 28 April 2020.

Timeline

16 March 2017

Primary endpoint
28 February 2019

28 April 2020

Quick facts

Lead sponsor	St Vincent's Hospital Melbourne
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	188
Start date	16 March 2017
Primary completion	28 February 2019
Estimated completion	28 April 2020
Sites	1 location across Australia

Drugs / interventions tested

Multi-disciplinary clinic model
Standard outpatient care

Conditions studied

Irritable Bowel Syndrome — all drugs for Irritable Bowel Syndrome →
Functional Dyspepsia — all drugs for Functional Dyspepsia →
Constipation - Functional — all drugs for Constipation - Functional →
Faecal Incontinence — all drugs for Faecal Incontinence →

Sponsor

St Vincent's Hospital Melbourne

Who can join

Adults 18 to 80, any sex, with Irritable Bowel Syndrome or Functional Dyspepsia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomised controlled trial comparing standard outpatient clinic treatment with multi-disciplinary clinic treatment for functional gastrointestinal disorders. Patients will be followed up to end of clinic treatment and 12 months beyond the end of treatment. Symptoms, quality of life, costs to the healthcare system and psychological outcomes will be assessed.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): an open-label, single-centre, randomised controlled trial.
Basnayake C, Kamm MA, Stanley A, Wilson-O'Brien A, et al · · 2020 · cited 89× · PMID 32679040 · DOI 10.1016/s2468-1253(20)30215-6
Long-Term Outcome of Multidisciplinary Versus Standard Gastroenterologist Care for Functional Gastrointestinal Disorders: A Randomized Trial.
Basnayake C, Kamm MA, Stanley A, Wilson-O'Brien A, et al · · 2022 · cited 38× · PMID 34896645 · DOI 10.1016/j.cgh.2021.12.005

Verify or expand the search:

Other recruiting trials for Irritable Bowel Syndrome

Currently open trials in the same condition.

NCT07235228 — Effects of Vivatlac Synbiotic on Gut Micribiota of IBS Patients · NA · recruiting
NCT07421011 — Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 · Phase 1 · recruiting
NCT07360938 — Drug Interaction Potential of Pro-Inflammatory Conditions · recruiting
NCT06788444 — Efficacy of Esketamine for Patients With Irritable Bowel Syndrome · NA · recruiting
NCT07484412 — Efficacy and Safety of Encapsulated Bifidobacterium Longum BBH016 in Subjects With Lower Gastrointestinal Symptoms · NA · active not recruiting

Other St Vincent's Hospital Melbourne trials

Trials by the same sponsor.

NCT06839248 — Effect of Fasting Recommendations Among Patients Using GLP-1 Receptor Agonists · NA · recruiting
NCT04970446 — Microbial Restoration in Inflammatory Bowel Diseases · Phase 1, PHASE2 · recruiting
NCT05442918 — Expected Normal Ketone Values After Very Low and Bariatric Surgery · completed
NCT03465189 — Validation of a Seizure Monitoring System · completed
NCT03477032 — FMT in Inflammatory Bowel Disease · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03078634 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by St Vincent's Hospital Melbourne
Last refreshed: 29 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03078634.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing